Insights from 2024 ESGO Annual Meeting
ESGO 2024 Insights: "COPELIA Trial - Cediranib With Weekly Paclitaxel or Olaparib vs. Weekly Paclitaxel Chemo for Advanced/Recurrent Endometrial Cancer"
By
Insights from 2024 ESGO Annual Meeting
FEATURING
Andrew Clamp
By
Insights from 2024 ESGO Annual Meeting
FEATURING
Andrew Clamp
Login to view comments.
Click here to Login